For the quarter ending 2026-03-31, OLMA has $530,645K in assets. $50,167K in debts. $52,547K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 52,547 | 48,301 | 35,260 | 52,473 |
| Marketable securities | 452,800 | 457,136 | 293,700 | 309,440 |
| Prepaid expenses and other current assets | 7,882 | 10,015 | 5,369 | 5,812 |
| Total current assets | 513,229 | 515,452 | 334,329 | 367,725 |
| Operating lease right-of-use assets | 921 | 1,146 | 1,419 | 1,685 |
| Other assets and long-term deposits | 16,495 | 16,832 | 16,705 | 12,592 |
| Total assets | 530,645 | 533,430 | 352,453 | 382,002 |
| Accounts payable | 3,719 | 9,253 | 3,474 | 934 |
| Current portion of operating lease liability | 956 | 1,124 | 1,168 | 1,153 |
| Other current liabilities | 42,492 | 41,425 | 37,013 | 31,077 |
| Total current liabilities | 47,167 | 51,802 | 41,655 | 33,164 |
| Operating lease liabilities, net of current portion | 0 | 69 | 310 | 602 |
| Long-term borrowing | 3,000 | 3,000 | 3,000 | 3,000 |
| Total liabilities | 50,167 | 54,871 | 44,965 | 36,766 |
| Common stock, 0.0001 par value 490,000,000 shares authorized as of march 31, 2026 and december 31, 2025 87,332,971 and 81,376,449 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 8 | 8 | 7 | 7 |
| Additional paid-in capital | 1,131,576 | 1,075,487 | 858,451 | 854,194 |
| Accumulated other comprehensive (loss) income | -460 | 621 | 526 | 314 |
| Accumulated deficit | -650,646 | -597,557 | -551,496 | -509,279 |
| Total stockholders' equity | 480,478 | 478,559 | 307,488 | 345,236 |
| Total liabilities and stockholders' equity | 530,645 | 533,430 | 352,453 | 382,002 |
Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (OLMA)